These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3955269)

  • 1. Paf-acether (platelet-activating factor).
    Benveniste J
    Bull Eur Physiopathol Respir; 1986; 22 Suppl 7():91-4. PubMed ID: 3955269
    [No Abstract]   [Full Text] [Related]  

  • 2. Biosynthesis and function of PAF-acether (platelet-activating factor).
    Benveniste J
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():689-91. PubMed ID: 2936197
    [No Abstract]   [Full Text] [Related]  

  • 3. Cutaneous and pulmonary histopathological responses to platelet activating factor (Paf-acether) in the guinea-pig.
    Dewar A; Archer CB; Paul W; Page CP; MacDonald DM; Morley J
    J Pathol; 1984 Sep; 144(1):25-34. PubMed ID: 6481526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paf-acether (platelet-activating factor).
    Benveniste J
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():11-8. PubMed ID: 3159192
    [No Abstract]   [Full Text] [Related]  

  • 5. Phospholipids, particularly platelet-activating factor (PAF-acether), in experimental bronchoconstriction.
    Vargaftig BB
    Agents Actions Suppl; 1983; 13():155-71. PubMed ID: 6575594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Platelet-activating factor: a new biochemical and pharmacologic frontier].
    Porcellini G
    Clin Ter; 1986 Apr; 117(2):127-32. PubMed ID: 3720244
    [No Abstract]   [Full Text] [Related]  

  • 7. A role for paf-acether (platelet-activating factor) in bronchial hyperreactivity?
    Benveniste J
    Am Rev Respir Dis; 1987 Jun; 135(6 Pt 2):S2-4. PubMed ID: 3592414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosynthesis of platelet-activating factor. VI. Precursor of platelet-activating factor and acetyltransferase activity in isolated rat kidney cells.
    Pirotzky E; Ninio E; Bidault J; Pfister A; Benveniste J
    Lab Invest; 1984 Nov; 51(5):567-72. PubMed ID: 6492758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synthesis and biologic activity of some stable structure analogs of platelet activating factor].
    Kertscher HP; Ostermann G; Lang A; Weissflog W; Gawrisch K
    Pharmazie; 1985 Oct; 40(10):702-4. PubMed ID: 4080785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.
    Mencia-Huerta JM; Lewis RA; Razin E; Austen KF
    J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAF-acether may not mediate the third pathway of platelet aggregation since self-desensitization reduces the effects of low thrombin but enhances those of convulxin.
    Wal F; Joseph D; Touqui L; Vargaftig BB
    Thromb Haemost; 1985 Feb; 53(1):99-104. PubMed ID: 3992525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAF-acether: a putative mediator of asthma and inflammation.
    Page CP; Paul W; Dewar A; Wood L; Basran GS; Morley J
    Agents Actions Suppl; 1983; 13():177-83. PubMed ID: 6575595
    [No Abstract]   [Full Text] [Related]  

  • 13. Degranulation of rabbit platelets with PAF-acether: a new procedure for unravelling the mode of action of platelet-activating substances.
    Vargaftig BB; Joseph D; Marlas G; Chevance LG
    Thromb Haemost; 1982 Aug; 48(1):67-71. PubMed ID: 7135345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of the oxidative burst in macrophages with platelet activating factor (PAF-acether).
    Hartung HP; Parnham MJ; Winkelmann J; Rasokat H; Hadding U
    Agents Actions Suppl; 1982; 11():139-46. PubMed ID: 6960648
    [No Abstract]   [Full Text] [Related]  

  • 15. [A bioregulator of lipid nature--a platelet activating factor (PAF)].
    Gordeev KIu; Serebrennikova GA; Evstigneeva RP
    Bioorg Khim; 1984 Dec; 10(12):1589-605. PubMed ID: 6099122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationship in PAF-acether. 3. Hydrophobic contribution to agonistic activity.
    Godfroid JJ; Broquet C; Jouquey S; Lebbar M; Heymans F; Redeuilh C; Steiner E; Michel E; Coeffier E; Fichelle J
    J Med Chem; 1987 May; 30(5):792-7. PubMed ID: 3572968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes.
    Jouvin-Marche E; Ninio E; Beaurain G; Tence M; Niaudet P; Benveniste J
    J Immunol; 1984 Aug; 133(2):892-8. PubMed ID: 6736649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific desensitization of rabbit platelets by platelet-activating factor (PAF-acether) and derivatives.
    Keraly CL; Benveniste J
    Br J Haematol; 1982 Jun; 51(2):313-22. PubMed ID: 7082588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1st International Symposium on Platelet-Activating Factor (PAF-ACETHER, AGEPC) and structurally related ether-lipids. Paris (France) June 26-29, 1983. Abstracts.
    J Pharmacol; 1983; 14 Suppl 1():1-104. PubMed ID: 6876807
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular and pulmonary activity of platelet-activating factor (PAF-acether) and its derivatives.
    Berti F; Ferri V; Pallavicini M; Pretolani M; Tremoli E; Valoti E; Villa L
    Pharmacol Res Commun; 1986 Jun; 18(6):557-62. PubMed ID: 3749244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.